S&P 500 bounces back after nearing August low
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/2/2026
- Wall Street ends higher as Amazon soothes AI jitters
- Amazon shares rally as cloud growth surges and spending outlook climbs
- Apple shares sink on disappointing September quarter sales outlook
- Novo Nordisk stock tumbles 10% as key trial misses goal
- AI wizkid Leopold Aschenbrenner forced to sell entire portfolio after rout
- SCYNEXIS (SCYX) Move Attributed to Morning Note from Brookline
- AbbVie (ABBV) Misses Q2 EPS by 6c, Beats on Revenue; Offers FY26 EPS Guidance
- Short sellers pile into SpaceX ahead of earnings, lockup expiration
- Wall Street ends higher as Amazon soothes AI jitters
- Novo Nordisk's ziltivekimab fails to reduce heart risk in ZEUS trial
- After-Hours Stock Movers: AAPL, AMZN, COIN, RBLX, RDDT, AXTI, FND, WU, GDDY
- After-Hours Stock Movers: META, MSFT, CMG, SBUX, CVNA, LRCX, FTNT, QCOM, TDOC
- After-Hours Stock Movers: F, BE, STX, WDC, KLAC, SWKS, NXPI, CSGP, ENPH
- After-Hours Stock Movers: FFIV, CDNS, APLD, RMBS, ESI, SANM
- After-Hours Stock Movers: INTC, AMD, ARM, MXL, EW, DECK
Buyers Seem Like Deer-in-Headlights: RBC Capital; Analyst Comments on Biotech Rout
September 29, 2015 11:00 AM EDTIn a research note after the close of trading Monday, RBC Capital discussed the recent sell-off in biotech stocks and key levels of support to watch for.
Analyst Michael J. Yee noted the pullback in the Nasdaq Biotech Index (Nasdaq: IBB) is similar to the pullback during the 2008 finance crisis and worse than the May through April 2014 pullback. While the original trigger for the sell-off was comments from Hillary Clinton related to drug pricing, Yee believes follow through was tied to selling by fund managers and hedge funds.
"... healthcare has historically... More
Imperial Capital Cuts Price Target on Republic Airways (RJET) as Management and Union Reach Tentative Agreement
September 29, 2015 10:57 AM EDTImperial Capital maintained an Outperform rating on Republic Airways (NASDAQ: RJET), and cut the price target to $8.00 (from $10.00), following the announcement that management and the pilots union had reached a tentative agreement on terms for a new three year contract. The terms of the tentative agreement have yet to be released publicly. This should remove a significant overhang in RJET shares and allow... More
